English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, October 28, 2022
兆科眼科的合作伙伴Vyluma发表用于治疗儿童近视加深的NVK002之第III期CHAMP临床试验的正面研究结果
兆科眼科的合作夥伴Vyluma發表用於治療兒童近視加深的NVK002之第III期CHAMP臨床試驗的正面研究結果
Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
Monday, September 19, 2022
兆科眼科入圍“2021年度中國生物醫藥企業創新力百強系列榜單”中國小分子藥物企業創新力TOP30排行榜
兆科眼科入围“2021年度中国生物医药企业创新力百强系列榜单”中国小分子药物企业创新力TOP30排行榜
Wednesday, August 24, 2022
兆科眼科公布2022中期业绩
兆科眼科公佈2022中期業績
Zhaoke Ophthalmology Announces 2022 Interim Results
Wednesday, August 3, 2022
兆科眼科以NVK002治疗近视加深的第III期临床试验完成患者入组
兆科眼科以NVK002治療近視加深的第III期臨床試驗完成患者入組

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575